
Visa is preparing to increase the fees it charges on behalf of banks on transactions between the United Kingdom and European Union countries beginning in October, the Financial Times (FT) reported, citing unnamed sources. These fees are called “interchange fees.”
Visa also plans to hike the fees on payments made within the UK with British credit cards, according to FT.
Visa will charge 1.5% of transaction value on online or telephone payments between the UK and EU, up from 0.3%, and 1.15% on debit card payments, up from 0.2%, FT reported. The fee increases are possible because England no longer is covered by an EU-wide ceiling on interchange fees that was imposed a half-dozen years ago.
FT quoted Craig Beaumont, head of External Affairs for England’s Federation of Small Business, as having said in response to news of the planned fee increases: “With the move to cashless and eCommerce accelerating, it’s vital that small business and consumer sentiment isn’t stifled by rising card costs, just as we’re trying to bounce back from a severe recession.”
Representatives of Visa and Mastercard have said it is the banks that issue cards, not their banks, that charge interchange fees, FT reported. Visa stated in regulatory filings that charging higher interchange fees is good for business because banks are eager to do business with card companies that glean more revenue for them.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas